By Melissa Lipman ( February 28, 2013, 7:00 PM EST) -- Merck & Co. Inc. urged the U.S. Supreme Court on Thursday to reject the Federal Trade Commission's bid for an "aggressive and overbroad" antitrust test for so-called pay-for-delay settlements, warning that the standard the watchdog proposed would effectively make the pharmaceutical patent settlements inherently illegal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.